International Flavors & Fragrances Inc. reports developments across flavors, fragrances, food ingredients, health and biosciences for customers in food, beverage, personal care, home care, pet health and related markets. News frequently covers ingredient innovation, application labs and natural-extraction capabilities, including vanilla work in Madagascar and LMR Naturals in perfumery, cosmetics and flavors.
Company updates also address probiotics and bioscience products such as HOWARU Pet and PureStrong, nutrition claims tied to soy protein, quarterly earnings releases, dividends, and other capital or financial disclosures.
On June 14, 2022, IFF launched its new GUARDIAN® product family, focusing on plant extract-based formulations for oxidation control in food and beverages. The global food antioxidant market is expected to reach USD 1.8 billion by 2025, driven by demand for packaged food and clean ingredients. GUARDIAN® SYNEROX HT can reduce frying oil waste by 30%, while GUARDIAN® VITAGREEN LOD employs innovative technology for incorporating green tea extract. These solutions aim to enhance food quality, safety, and sustainability, addressing supply chain challenges and reducing food waste.
Summary not available.
IFF (NYSE: IFF) announced that CEO Frank Clyburn will participate in a fireside chat at the Bernstein 2022 Strategic Decisions Conference on June 1, 2022, at 8 am ET. Investors can access the live webcast through the company's website at ir.iff.com. A recorded version will also be available for replay.
IFF is a leader in food, beverage, scent, health, and biosciences, providing essential solutions for global markets.
International Flavors & Fragrances reported strong first quarter 2022 results with net sales of $3.23 billion, marking a 31% increase year-over-year. Adjusted operating EBITDA increased to $702 million, up 23% from the previous year. CEO Frank Clyburn highlighted growth across all segments, particularly in Nourish, Health & Biosciences, and Pharma Solutions. The company raised its full-year sales forecast to $12.6-$13.0 billion, anticipating continued growth despite inflationary pressures. However, a negative currency impact is expected to reduce sales and EBITDA growth by approximately 4% and 5%, respectively.
IFF (NYSE: IFF) has declared a quarterly cash dividend of $0.79 per share, set to be paid on July 6, 2022, to shareholders on record by June 24, 2022. This announcement underscores IFF's commitment to returning value to its investors. The company continues to lead in food, beverage, scent, health, and biosciences, offering innovative solutions and experiences. IFF aims to combine art and science to meet global consumer demands while promoting sustainability.
On May 3, 2022, IFF announced its expanded portfolio of nutritional ingredients and supplements ahead of Vitafoods Europe, taking place from May 10-12. The showcase will highlight their capabilities in botanicals and plant-based applications. Notable offerings include new probiotic combinations for women's health and innovative, sustainable supplements like GRINDSTED® Pectin PRM. IFF also emphasizes advancements in taste-masking bitter botanicals and novel delivery formats. The company aims to assist supplement manufacturers in developing high-quality products that meet evolving consumer demands.
IFF has launched SEAFLOUR™, a nutrient-dense hydrocolloid derived from non-GMO red seaweed, catering to the growing demand for clean label products in the U.S. The ingredient is suitable for plant-based beverages, offering stability, texture, and nutritional benefits without allergens. SEAFLOUR™ aids manufacturers in reducing fat and sugar levels while enhancing product quality. The sourcing supports local farming and aligns with IFF's 2030 sustainability goals, including responsible-seaweed practices.
IFF (NYSE: IFF) will release its first quarter 2022 earnings results after market close on May 9, 2022. A live webcast discussing the results will be hosted by management on May 10, 2022, at 9:00 a.m. ET. Investors can access the webcast and slide presentation on the company's website, with a recorded version available for playback. IFF is a leader in food, beverage, health, biosciences, and scent, providing innovative solutions to meet global needs.
Smart Cups has announced a multi-year collaboration with IFF, focusing on sustainable consumer products in the health and wellness sector. This partnership will leverage IFF's extensive ingredient portfolio and Smart Cups Technology, which allows for printing ingredients directly on surfaces. The initiative aims to reduce carbon footprints by minimizing the need to ship liquids. Products developed through this collaboration are scheduled for release in 2022, with a broader goal of advancing eco-conscious manufacturing practices.
IFF (NYSE: IFF) has finalized its acquisition of Health Wright Products (HWP), a prominent player in dietary supplement formulation and manufacturing. Known for high-quality nutritional supplements, HWP will enhance IFF's Health & Biosciences division, focusing on probiotic products. The acquisition will retain HWP’s workforce of over 225 employees, and IFF plans to expand HWP's capabilities to meet customer demands. Financial terms of the deal remain undisclosed. This strategic move aims to strengthen IFF’s market position in health and nutrition.